nodes	percent_of_prediction	percent_of_DWPC	metapath
Estazolam—CYP3A4—Topotecan—lung cancer	0.0229	0.142	CbGbCtD
Estazolam—CYP3A4—Gefitinib—lung cancer	0.0209	0.13	CbGbCtD
Estazolam—CYP3A4—Teniposide—lung cancer	0.0203	0.126	CbGbCtD
Estazolam—CYP3A4—Vinorelbine—lung cancer	0.0161	0.1	CbGbCtD
Estazolam—CYP3A4—Crizotinib—lung cancer	0.0128	0.0796	CbGbCtD
Estazolam—CYP3A4—Erlotinib—lung cancer	0.0124	0.0768	CbGbCtD
Estazolam—CYP3A4—Paclitaxel—lung cancer	0.0113	0.0703	CbGbCtD
Estazolam—CYP3A4—Irinotecan—lung cancer	0.0112	0.0694	CbGbCtD
Estazolam—CYP3A4—Vinblastine—lung cancer	0.00994	0.0617	CbGbCtD
Estazolam—CYP3A4—Etoposide—lung cancer	0.00895	0.0556	CbGbCtD
Estazolam—CYP3A4—Docetaxel—lung cancer	0.00819	0.0508	CbGbCtD
Estazolam—CYP3A4—Doxorubicin—lung cancer	0.00611	0.0379	CbGbCtD
Estazolam—Flunitrazepam—UGT1A1—lung cancer	0.0014	0.149	CrCbGaD
Estazolam—Flunitrazepam—CYP2A6—lung cancer	0.000879	0.0939	CrCbGaD
Estazolam—Clonazepam—CYP2E1—lung cancer	0.000777	0.083	CrCbGaD
Estazolam—Flurazepam—CYP2A6—lung cancer	0.000705	0.0754	CrCbGaD
Estazolam—Flunitrazepam—CYP2E1—lung cancer	0.000624	0.0667	CrCbGaD
Estazolam—Nitrazepam—CYP2E1—lung cancer	0.000563	0.0602	CrCbGaD
Estazolam—Ketazolam—ALB—lung cancer	0.00053	0.0566	CrCbGaD
Estazolam—Decreased appetite—Gemcitabine—lung cancer	0.000527	0.000844	CcSEcCtD
Estazolam—Nausea—Topotecan—lung cancer	0.000524	0.000839	CcSEcCtD
Estazolam—Discomfort—Paclitaxel—lung cancer	0.000523	0.000838	CcSEcCtD
Estazolam—Confusional state—Etoposide—lung cancer	0.000522	0.000836	CcSEcCtD
Estazolam—Constipation—Gemcitabine—lung cancer	0.000519	0.00083	CcSEcCtD
Estazolam—Pain—Gemcitabine—lung cancer	0.000519	0.00083	CcSEcCtD
Estazolam—Nausea—Erlotinib—lung cancer	0.000519	0.00083	CcSEcCtD
Estazolam—Dry mouth—Paclitaxel—lung cancer	0.000518	0.000829	CcSEcCtD
Estazolam—Mood swings—Doxorubicin—lung cancer	0.000518	0.000829	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000515	0.000825	CcSEcCtD
Estazolam—Ataxia—Doxorubicin—lung cancer	0.000514	0.000823	CcSEcCtD
Estazolam—Feeling abnormal—Irinotecan—lung cancer	0.000513	0.000821	CcSEcCtD
Estazolam—Confusional state—Paclitaxel—lung cancer	0.000512	0.00082	CcSEcCtD
Estazolam—Back pain—Docetaxel—lung cancer	0.00051	0.000817	CcSEcCtD
Estazolam—Gastrointestinal pain—Irinotecan—lung cancer	0.000509	0.000815	CcSEcCtD
Estazolam—Oedema—Paclitaxel—lung cancer	0.000508	0.000813	CcSEcCtD
Estazolam—Paraesthesia—Cisplatin—lung cancer	0.000508	0.000813	CcSEcCtD
Estazolam—Muscle spasms—Docetaxel—lung cancer	0.000507	0.000812	CcSEcCtD
Estazolam—Ketazolam—ABCB1—lung cancer	0.000506	0.054	CrCbGaD
Estazolam—Dyspnoea—Cisplatin—lung cancer	0.000504	0.000807	CcSEcCtD
Estazolam—Flurazepam—CYP2E1—lung cancer	0.000501	0.0535	CrCbGaD
Estazolam—Dry skin—Doxorubicin—lung cancer	0.000501	0.000802	CcSEcCtD
Estazolam—Hyperhidrosis—Etoposide—lung cancer	0.000501	0.000802	CcSEcCtD
Estazolam—Feeling abnormal—Gemcitabine—lung cancer	0.0005	0.0008	CcSEcCtD
Estazolam—Shock—Paclitaxel—lung cancer	0.000499	0.0008	CcSEcCtD
Estazolam—Dizziness—Vinorelbine—lung cancer	0.000499	0.000799	CcSEcCtD
Estazolam—Photosensitivity reaction—Methotrexate—lung cancer	0.000498	0.000797	CcSEcCtD
Estazolam—Abdominal pain—Irinotecan—lung cancer	0.000492	0.000788	CcSEcCtD
Estazolam—Body temperature increased—Irinotecan—lung cancer	0.000492	0.000788	CcSEcCtD
Estazolam—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000492	0.000788	CcSEcCtD
Estazolam—Decreased appetite—Cisplatin—lung cancer	0.000491	0.000787	CcSEcCtD
Estazolam—Hyperhidrosis—Paclitaxel—lung cancer	0.000491	0.000786	CcSEcCtD
Estazolam—Nasopharyngitis—Doxorubicin—lung cancer	0.000489	0.000782	CcSEcCtD
Estazolam—Depression—Methotrexate—lung cancer	0.000485	0.000776	CcSEcCtD
Estazolam—Gastritis—Doxorubicin—lung cancer	0.000484	0.000774	CcSEcCtD
Estazolam—Pain—Cisplatin—lung cancer	0.000483	0.000774	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000482	0.000772	CcSEcCtD
Estazolam—Vomiting—Vinorelbine—lung cancer	0.00048	0.000768	CcSEcCtD
Estazolam—Body temperature increased—Gemcitabine—lung cancer	0.000479	0.000768	CcSEcCtD
Estazolam—Rash—Vinorelbine—lung cancer	0.000476	0.000762	CcSEcCtD
Estazolam—Dermatitis—Vinorelbine—lung cancer	0.000475	0.000761	CcSEcCtD
Estazolam—Headache—Vinorelbine—lung cancer	0.000473	0.000757	CcSEcCtD
Estazolam—Syncope—Docetaxel—lung cancer	0.000473	0.000757	CcSEcCtD
Estazolam—Asthma—Doxorubicin—lung cancer	0.000472	0.000756	CcSEcCtD
Estazolam—Leukopenia—Docetaxel—lung cancer	0.000472	0.000756	CcSEcCtD
Estazolam—Sweating—Methotrexate—lung cancer	0.000466	0.000747	CcSEcCtD
Estazolam—Palpitations—Docetaxel—lung cancer	0.000466	0.000746	CcSEcCtD
Estazolam—Feeling abnormal—Cisplatin—lung cancer	0.000466	0.000746	CcSEcCtD
Estazolam—Paraesthesia—Etoposide—lung cancer	0.000465	0.000745	CcSEcCtD
Estazolam—Midazolam—CYP2E1—lung cancer	0.000464	0.0496	CrCbGaD
Estazolam—Haematuria—Methotrexate—lung cancer	0.000464	0.000742	CcSEcCtD
Estazolam—Loss of consciousness—Docetaxel—lung cancer	0.000463	0.000742	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000463	0.000741	CcSEcCtD
Estazolam—Dyspnoea—Etoposide—lung cancer	0.000462	0.000739	CcSEcCtD
Estazolam—Somnolence—Etoposide—lung cancer	0.00046	0.000737	CcSEcCtD
Estazolam—Cough—Docetaxel—lung cancer	0.00046	0.000737	CcSEcCtD
Estazolam—Epistaxis—Methotrexate—lung cancer	0.000459	0.000734	CcSEcCtD
Estazolam—Hypersensitivity—Irinotecan—lung cancer	0.000459	0.000734	CcSEcCtD
Estazolam—Convulsion—Docetaxel—lung cancer	0.000457	0.000732	CcSEcCtD
Estazolam—Paraesthesia—Paclitaxel—lung cancer	0.000456	0.00073	CcSEcCtD
Estazolam—Agranulocytosis—Methotrexate—lung cancer	0.000454	0.000727	CcSEcCtD
Estazolam—Dyspnoea—Paclitaxel—lung cancer	0.000453	0.000725	CcSEcCtD
Estazolam—Somnolence—Paclitaxel—lung cancer	0.000451	0.000723	CcSEcCtD
Estazolam—Decreased appetite—Etoposide—lung cancer	0.00045	0.000721	CcSEcCtD
Estazolam—Arthralgia—Docetaxel—lung cancer	0.000449	0.000719	CcSEcCtD
Estazolam—Myalgia—Docetaxel—lung cancer	0.000449	0.000719	CcSEcCtD
Estazolam—Chest pain—Docetaxel—lung cancer	0.000449	0.000719	CcSEcCtD
Estazolam—Nausea—Vinorelbine—lung cancer	0.000448	0.000718	CcSEcCtD
Estazolam—Dyspepsia—Paclitaxel—lung cancer	0.000447	0.000716	CcSEcCtD
Estazolam—Body temperature increased—Cisplatin—lung cancer	0.000447	0.000715	CcSEcCtD
Estazolam—Asthenia—Irinotecan—lung cancer	0.000447	0.000715	CcSEcCtD
Estazolam—Constipation—Etoposide—lung cancer	0.000443	0.000709	CcSEcCtD
Estazolam—Pain—Etoposide—lung cancer	0.000443	0.000709	CcSEcCtD
Estazolam—Decreased appetite—Paclitaxel—lung cancer	0.000441	0.000707	CcSEcCtD
Estazolam—Dry mouth—Docetaxel—lung cancer	0.000439	0.000703	CcSEcCtD
Estazolam—Pollakiuria—Doxorubicin—lung cancer	0.000436	0.000699	CcSEcCtD
Estazolam—Asthenia—Gemcitabine—lung cancer	0.000435	0.000697	CcSEcCtD
Estazolam—Constipation—Paclitaxel—lung cancer	0.000434	0.000695	CcSEcCtD
Estazolam—Pain—Paclitaxel—lung cancer	0.000434	0.000695	CcSEcCtD
Estazolam—Confusional state—Docetaxel—lung cancer	0.000434	0.000695	CcSEcCtD
Estazolam—Pharyngitis—Methotrexate—lung cancer	0.000433	0.000694	CcSEcCtD
Estazolam—Photosensitivity reaction—Doxorubicin—lung cancer	0.000431	0.00069	CcSEcCtD
Estazolam—Oedema—Docetaxel—lung cancer	0.00043	0.000689	CcSEcCtD
Estazolam—Weight increased—Doxorubicin—lung cancer	0.00043	0.000688	CcSEcCtD
Estazolam—Pruritus—Gemcitabine—lung cancer	0.000429	0.000687	CcSEcCtD
Estazolam—Weight decreased—Doxorubicin—lung cancer	0.000427	0.000684	CcSEcCtD
Estazolam—Clonazepam—ALB—lung cancer	0.000427	0.0456	CrCbGaD
Estazolam—Feeling abnormal—Etoposide—lung cancer	0.000427	0.000683	CcSEcCtD
Estazolam—Gastrointestinal pain—Etoposide—lung cancer	0.000423	0.000678	CcSEcCtD
Estazolam—Shock—Docetaxel—lung cancer	0.000423	0.000678	CcSEcCtD
Estazolam—Visual impairment—Methotrexate—lung cancer	0.000421	0.000674	CcSEcCtD
Estazolam—Feeling abnormal—Paclitaxel—lung cancer	0.000418	0.00067	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000417	0.000669	CcSEcCtD
Estazolam—Hypersensitivity—Cisplatin—lung cancer	0.000416	0.000667	CcSEcCtD
Estazolam—Gastrointestinal pain—Paclitaxel—lung cancer	0.000415	0.000665	CcSEcCtD
Estazolam—Erythema multiforme—Methotrexate—lung cancer	0.000413	0.000661	CcSEcCtD
Estazolam—Neuropathy peripheral—Doxorubicin—lung cancer	0.000413	0.000661	CcSEcCtD
Estazolam—Dizziness—Irinotecan—lung cancer	0.000412	0.000659	CcSEcCtD
Estazolam—Urticaria—Etoposide—lung cancer	0.000411	0.000659	CcSEcCtD
Estazolam—Abdominal pain—Etoposide—lung cancer	0.000409	0.000655	CcSEcCtD
Estazolam—Body temperature increased—Etoposide—lung cancer	0.000409	0.000655	CcSEcCtD
Estazolam—Tinnitus—Methotrexate—lung cancer	0.000407	0.000652	CcSEcCtD
Estazolam—Asthenia—Cisplatin—lung cancer	0.000406	0.000649	CcSEcCtD
Estazolam—Sweating—Doxorubicin—lung cancer	0.000404	0.000646	CcSEcCtD
Estazolam—Urticaria—Paclitaxel—lung cancer	0.000403	0.000646	CcSEcCtD
Estazolam—Haematuria—Doxorubicin—lung cancer	0.000401	0.000643	CcSEcCtD
Estazolam—Abdominal pain—Paclitaxel—lung cancer	0.000401	0.000643	CcSEcCtD
Estazolam—Body temperature increased—Paclitaxel—lung cancer	0.000401	0.000643	CcSEcCtD
Estazolam—Diazepam—CYP2E1—lung cancer	0.000398	0.0425	CrCbGaD
Estazolam—Epistaxis—Doxorubicin—lung cancer	0.000397	0.000636	CcSEcCtD
Estazolam—Vomiting—Irinotecan—lung cancer	0.000396	0.000634	CcSEcCtD
Estazolam—Sinusitis—Doxorubicin—lung cancer	0.000395	0.000633	CcSEcCtD
Estazolam—Agranulocytosis—Doxorubicin—lung cancer	0.000393	0.000629	CcSEcCtD
Estazolam—Rash—Irinotecan—lung cancer	0.000393	0.000629	CcSEcCtD
Estazolam—Dermatitis—Irinotecan—lung cancer	0.000392	0.000628	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000392	0.000628	CcSEcCtD
Estazolam—Chills—Methotrexate—lung cancer	0.000392	0.000627	CcSEcCtD
Estazolam—Headache—Irinotecan—lung cancer	0.00039	0.000624	CcSEcCtD
Estazolam—Paraesthesia—Docetaxel—lung cancer	0.000386	0.000619	CcSEcCtD
Estazolam—Vomiting—Gemcitabine—lung cancer	0.000386	0.000617	CcSEcCtD
Estazolam—Dyspnoea—Docetaxel—lung cancer	0.000384	0.000614	CcSEcCtD
Estazolam—Somnolence—Docetaxel—lung cancer	0.000383	0.000613	CcSEcCtD
Estazolam—Rash—Gemcitabine—lung cancer	0.000382	0.000612	CcSEcCtD
Estazolam—Dermatitis—Gemcitabine—lung cancer	0.000382	0.000612	CcSEcCtD
Estazolam—Hypersensitivity—Etoposide—lung cancer	0.000381	0.000611	CcSEcCtD
Estazolam—Malnutrition—Methotrexate—lung cancer	0.00038	0.000609	CcSEcCtD
Estazolam—Headache—Gemcitabine—lung cancer	0.00038	0.000608	CcSEcCtD
Estazolam—Rhinitis—Doxorubicin—lung cancer	0.000379	0.000607	CcSEcCtD
Estazolam—Dyspepsia—Docetaxel—lung cancer	0.000379	0.000607	CcSEcCtD
Estazolam—Pharyngitis—Doxorubicin—lung cancer	0.000375	0.000601	CcSEcCtD
Estazolam—Decreased appetite—Docetaxel—lung cancer	0.000374	0.000599	CcSEcCtD
Estazolam—Hypersensitivity—Paclitaxel—lung cancer	0.000374	0.000599	CcSEcCtD
Estazolam—Asthenia—Etoposide—lung cancer	0.000372	0.000595	CcSEcCtD
Estazolam—Nausea—Irinotecan—lung cancer	0.00037	0.000592	CcSEcCtD
Estazolam—Pain—Docetaxel—lung cancer	0.000368	0.000589	CcSEcCtD
Estazolam—Constipation—Docetaxel—lung cancer	0.000368	0.000589	CcSEcCtD
Estazolam—Back pain—Methotrexate—lung cancer	0.000368	0.000589	CcSEcCtD
Estazolam—Pruritus—Etoposide—lung cancer	0.000366	0.000587	CcSEcCtD
Estazolam—Visual impairment—Doxorubicin—lung cancer	0.000364	0.000583	CcSEcCtD
Estazolam—Asthenia—Paclitaxel—lung cancer	0.000364	0.000583	CcSEcCtD
Estazolam—Nausea—Gemcitabine—lung cancer	0.00036	0.000577	CcSEcCtD
Estazolam—Vomiting—Cisplatin—lung cancer	0.000359	0.000575	CcSEcCtD
Estazolam—Pruritus—Paclitaxel—lung cancer	0.000359	0.000575	CcSEcCtD
Estazolam—Erythema multiforme—Doxorubicin—lung cancer	0.000357	0.000572	CcSEcCtD
Estazolam—Clobazam—ABCB1—lung cancer	0.000357	0.0382	CrCbGaD
Estazolam—Rash—Cisplatin—lung cancer	0.000356	0.000571	CcSEcCtD
Estazolam—Dermatitis—Cisplatin—lung cancer	0.000356	0.00057	CcSEcCtD
Estazolam—Feeling abnormal—Docetaxel—lung cancer	0.000355	0.000568	CcSEcCtD
Estazolam—Ill-defined disorder—Methotrexate—lung cancer	0.000353	0.000565	CcSEcCtD
Estazolam—Tinnitus—Doxorubicin—lung cancer	0.000352	0.000564	CcSEcCtD
Estazolam—Gastrointestinal pain—Docetaxel—lung cancer	0.000352	0.000563	CcSEcCtD
Estazolam—Flushing—Doxorubicin—lung cancer	0.000351	0.000562	CcSEcCtD
Estazolam—Malaise—Methotrexate—lung cancer	0.000343	0.000549	CcSEcCtD
Estazolam—Dizziness—Etoposide—lung cancer	0.000342	0.000548	CcSEcCtD
Estazolam—Abdominal pain—Docetaxel—lung cancer	0.00034	0.000545	CcSEcCtD
Estazolam—Body temperature increased—Docetaxel—lung cancer	0.00034	0.000545	CcSEcCtD
Estazolam—Leukopenia—Methotrexate—lung cancer	0.00034	0.000545	CcSEcCtD
Estazolam—Chills—Doxorubicin—lung cancer	0.000339	0.000543	CcSEcCtD
Estazolam—Arrhythmia—Doxorubicin—lung cancer	0.000338	0.000541	CcSEcCtD
Estazolam—Dizziness—Paclitaxel—lung cancer	0.000336	0.000538	CcSEcCtD
Estazolam—Nausea—Cisplatin—lung cancer	0.000336	0.000538	CcSEcCtD
Estazolam—Cough—Methotrexate—lung cancer	0.000332	0.000531	CcSEcCtD
Estazolam—Convulsion—Methotrexate—lung cancer	0.000329	0.000527	CcSEcCtD
Estazolam—Vomiting—Etoposide—lung cancer	0.000329	0.000527	CcSEcCtD
Estazolam—Malnutrition—Doxorubicin—lung cancer	0.000329	0.000527	CcSEcCtD
Estazolam—Rash—Etoposide—lung cancer	0.000326	0.000523	CcSEcCtD
Estazolam—Dermatitis—Etoposide—lung cancer	0.000326	0.000522	CcSEcCtD
Estazolam—Headache—Etoposide—lung cancer	0.000324	0.000519	CcSEcCtD
Estazolam—Flatulence—Doxorubicin—lung cancer	0.000324	0.000519	CcSEcCtD
Estazolam—Chest pain—Methotrexate—lung cancer	0.000324	0.000518	CcSEcCtD
Estazolam—Arthralgia—Methotrexate—lung cancer	0.000324	0.000518	CcSEcCtD
Estazolam—Myalgia—Methotrexate—lung cancer	0.000324	0.000518	CcSEcCtD
Estazolam—Tension—Doxorubicin—lung cancer	0.000323	0.000517	CcSEcCtD
Estazolam—Vomiting—Paclitaxel—lung cancer	0.000323	0.000517	CcSEcCtD
Estazolam—Rash—Paclitaxel—lung cancer	0.00032	0.000513	CcSEcCtD
Estazolam—Dermatitis—Paclitaxel—lung cancer	0.00032	0.000512	CcSEcCtD
Estazolam—Discomfort—Methotrexate—lung cancer	0.00032	0.000512	CcSEcCtD
Estazolam—Nervousness—Doxorubicin—lung cancer	0.00032	0.000512	CcSEcCtD
Estazolam—Back pain—Doxorubicin—lung cancer	0.000318	0.00051	CcSEcCtD
Estazolam—Headache—Paclitaxel—lung cancer	0.000318	0.000509	CcSEcCtD
Estazolam—Hypersensitivity—Docetaxel—lung cancer	0.000317	0.000508	CcSEcCtD
Estazolam—Muscle spasms—Doxorubicin—lung cancer	0.000316	0.000507	CcSEcCtD
Estazolam—Confusional state—Methotrexate—lung cancer	0.000313	0.000501	CcSEcCtD
Estazolam—Asthenia—Docetaxel—lung cancer	0.000309	0.000494	CcSEcCtD
Estazolam—Nausea—Etoposide—lung cancer	0.000308	0.000493	CcSEcCtD
Estazolam—Ill-defined disorder—Doxorubicin—lung cancer	0.000305	0.000489	CcSEcCtD
Estazolam—Pruritus—Docetaxel—lung cancer	0.000304	0.000488	CcSEcCtD
Estazolam—Agitation—Doxorubicin—lung cancer	0.000302	0.000484	CcSEcCtD
Estazolam—Nausea—Paclitaxel—lung cancer	0.000302	0.000483	CcSEcCtD
Estazolam—Hyperhidrosis—Methotrexate—lung cancer	0.0003	0.00048	CcSEcCtD
Estazolam—Malaise—Doxorubicin—lung cancer	0.000297	0.000475	CcSEcCtD
Estazolam—Nitrazepam—ABCB1—lung cancer	0.000295	0.0316	CrCbGaD
Estazolam—Syncope—Doxorubicin—lung cancer	0.000295	0.000473	CcSEcCtD
Estazolam—Leukopenia—Doxorubicin—lung cancer	0.000295	0.000472	CcSEcCtD
Estazolam—Palpitations—Doxorubicin—lung cancer	0.000291	0.000466	CcSEcCtD
Estazolam—Loss of consciousness—Doxorubicin—lung cancer	0.000289	0.000463	CcSEcCtD
Estazolam—Cough—Doxorubicin—lung cancer	0.000287	0.00046	CcSEcCtD
Estazolam—Convulsion—Doxorubicin—lung cancer	0.000285	0.000457	CcSEcCtD
Estazolam—Dizziness—Docetaxel—lung cancer	0.000285	0.000456	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000283	0.000452	CcSEcCtD
Estazolam—Arthralgia—Doxorubicin—lung cancer	0.00028	0.000449	CcSEcCtD
Estazolam—Chest pain—Doxorubicin—lung cancer	0.00028	0.000449	CcSEcCtD
Estazolam—Myalgia—Doxorubicin—lung cancer	0.00028	0.000449	CcSEcCtD
Estazolam—Anxiety—Doxorubicin—lung cancer	0.000279	0.000447	CcSEcCtD
Estazolam—Paraesthesia—Methotrexate—lung cancer	0.000279	0.000446	CcSEcCtD
Estazolam—Discomfort—Doxorubicin—lung cancer	0.000277	0.000443	CcSEcCtD
Estazolam—Dyspnoea—Methotrexate—lung cancer	0.000277	0.000443	CcSEcCtD
Estazolam—Somnolence—Methotrexate—lung cancer	0.000276	0.000442	CcSEcCtD
Estazolam—Dry mouth—Doxorubicin—lung cancer	0.000274	0.000439	CcSEcCtD
Estazolam—Vomiting—Docetaxel—lung cancer	0.000274	0.000438	CcSEcCtD
Estazolam—Dyspepsia—Methotrexate—lung cancer	0.000273	0.000437	CcSEcCtD
Estazolam—Rash—Docetaxel—lung cancer	0.000271	0.000434	CcSEcCtD
Estazolam—Dermatitis—Docetaxel—lung cancer	0.000271	0.000434	CcSEcCtD
Estazolam—Confusional state—Doxorubicin—lung cancer	0.000271	0.000434	CcSEcCtD
Estazolam—Decreased appetite—Methotrexate—lung cancer	0.00027	0.000432	CcSEcCtD
Estazolam—Headache—Docetaxel—lung cancer	0.00027	0.000432	CcSEcCtD
Estazolam—Oedema—Doxorubicin—lung cancer	0.000269	0.00043	CcSEcCtD
Estazolam—Pain—Methotrexate—lung cancer	0.000265	0.000425	CcSEcCtD
Estazolam—Shock—Doxorubicin—lung cancer	0.000264	0.000423	CcSEcCtD
Estazolam—Flurazepam—ABCB1—lung cancer	0.000263	0.0281	CrCbGaD
Estazolam—Hyperhidrosis—Doxorubicin—lung cancer	0.00026	0.000416	CcSEcCtD
Estazolam—Nausea—Docetaxel—lung cancer	0.000256	0.000409	CcSEcCtD
Estazolam—Feeling abnormal—Methotrexate—lung cancer	0.000256	0.000409	CcSEcCtD
Estazolam—Gastrointestinal pain—Methotrexate—lung cancer	0.000254	0.000406	CcSEcCtD
Estazolam—Urticaria—Methotrexate—lung cancer	0.000246	0.000395	CcSEcCtD
Estazolam—Abdominal pain—Methotrexate—lung cancer	0.000245	0.000393	CcSEcCtD
Estazolam—Body temperature increased—Methotrexate—lung cancer	0.000245	0.000393	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000245	0.000392	CcSEcCtD
Estazolam—Midazolam—ABCB1—lung cancer	0.000243	0.026	CrCbGaD
Estazolam—Paraesthesia—Doxorubicin—lung cancer	0.000241	0.000386	CcSEcCtD
Estazolam—Dyspnoea—Doxorubicin—lung cancer	0.000239	0.000383	CcSEcCtD
Estazolam—Somnolence—Doxorubicin—lung cancer	0.000239	0.000382	CcSEcCtD
Estazolam—Dyspepsia—Doxorubicin—lung cancer	0.000236	0.000379	CcSEcCtD
Estazolam—Decreased appetite—Doxorubicin—lung cancer	0.000233	0.000374	CcSEcCtD
Estazolam—Pain—Doxorubicin—lung cancer	0.00023	0.000368	CcSEcCtD
Estazolam—Constipation—Doxorubicin—lung cancer	0.00023	0.000368	CcSEcCtD
Estazolam—Hypersensitivity—Methotrexate—lung cancer	0.000229	0.000366	CcSEcCtD
Estazolam—Asthenia—Methotrexate—lung cancer	0.000223	0.000356	CcSEcCtD
Estazolam—Feeling abnormal—Doxorubicin—lung cancer	0.000221	0.000354	CcSEcCtD
Estazolam—Gastrointestinal pain—Doxorubicin—lung cancer	0.00022	0.000352	CcSEcCtD
Estazolam—Pruritus—Methotrexate—lung cancer	0.000219	0.000351	CcSEcCtD
Estazolam—Diazepam—ALB—lung cancer	0.000219	0.0234	CrCbGaD
Estazolam—Urticaria—Doxorubicin—lung cancer	0.000213	0.000342	CcSEcCtD
Estazolam—Abdominal pain—Doxorubicin—lung cancer	0.000212	0.00034	CcSEcCtD
Estazolam—Body temperature increased—Doxorubicin—lung cancer	0.000212	0.00034	CcSEcCtD
Estazolam—Diazepam—ABCB1—lung cancer	0.000209	0.0223	CrCbGaD
Estazolam—Dizziness—Methotrexate—lung cancer	0.000205	0.000328	CcSEcCtD
Estazolam—Hypersensitivity—Doxorubicin—lung cancer	0.000198	0.000317	CcSEcCtD
Estazolam—Vomiting—Methotrexate—lung cancer	0.000197	0.000316	CcSEcCtD
Estazolam—Rash—Methotrexate—lung cancer	0.000196	0.000313	CcSEcCtD
Estazolam—Dermatitis—Methotrexate—lung cancer	0.000195	0.000313	CcSEcCtD
Estazolam—Headache—Methotrexate—lung cancer	0.000194	0.000311	CcSEcCtD
Estazolam—Asthenia—Doxorubicin—lung cancer	0.000193	0.000309	CcSEcCtD
Estazolam—Pruritus—Doxorubicin—lung cancer	0.00019	0.000304	CcSEcCtD
Estazolam—Nausea—Methotrexate—lung cancer	0.000184	0.000295	CcSEcCtD
Estazolam—Dizziness—Doxorubicin—lung cancer	0.000178	0.000284	CcSEcCtD
Estazolam—Vomiting—Doxorubicin—lung cancer	0.000171	0.000273	CcSEcCtD
Estazolam—Rash—Doxorubicin—lung cancer	0.000169	0.000271	CcSEcCtD
Estazolam—Dermatitis—Doxorubicin—lung cancer	0.000169	0.000271	CcSEcCtD
Estazolam—Headache—Doxorubicin—lung cancer	0.000168	0.000269	CcSEcCtD
Estazolam—Nausea—Doxorubicin—lung cancer	0.00016	0.000255	CcSEcCtD
Estazolam—GABRG3—Neuronal System—BRAF—lung cancer	0.000141	0.000688	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—CASP3—lung cancer	0.000141	0.000686	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000141	0.000685	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000141	0.000685	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—AVP—lung cancer	0.00014	0.000684	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—TF—lung cancer	0.00014	0.000684	CbGpPWpGaD
Estazolam—GABRG2—Ion channel transport—RAF1—lung cancer	0.00014	0.000683	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—BRAF—lung cancer	0.000139	0.000677	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000138	0.000673	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000138	0.000673	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000138	0.000673	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000138	0.000671	CbGpPWpGaD
Estazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000137	0.000667	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—JUN—lung cancer	0.000137	0.000666	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—TF—lung cancer	0.000136	0.000665	CbGpPWpGaD
Estazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000136	0.000664	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000136	0.000663	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.000135	0.000657	CbGpPWpGaD
Estazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000134	0.000655	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—GNG11—lung cancer	0.000134	0.000654	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—TF—lung cancer	0.000134	0.000653	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.000133	0.000648	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—TF—lung cancer	0.000132	0.000641	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.000131	0.00064	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—TF—lung cancer	0.000131	0.000637	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—MDM2—lung cancer	0.00013	0.000633	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—RAF1—lung cancer	0.000129	0.000631	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—TF—lung cancer	0.000128	0.000626	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000127	0.000618	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—MDM2—lung cancer	0.000126	0.000615	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—RAF1—lung cancer	0.000126	0.000613	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—BRAF—lung cancer	0.000124	0.000604	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—MDM2—lung cancer	0.000124	0.000604	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—RAF1—lung cancer	0.000123	0.000602	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—SRC—lung cancer	0.000123	0.000598	CbGpPWpGaD
Estazolam—GABRA1—Ion channel transport—RAF1—lung cancer	0.000122	0.000597	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—MDM2—lung cancer	0.000122	0.000593	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—RAF1—lung cancer	0.000121	0.000591	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—MDM2—lung cancer	0.000121	0.00059	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000121	0.000588	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000121	0.000588	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—RAF1—lung cancer	0.00012	0.000587	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.00012	0.000583	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—MDM2—lung cancer	0.000119	0.000579	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—BRAF—lung cancer	0.000119	0.000579	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000118	0.000577	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—RAF1—lung cancer	0.000118	0.000577	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—STAT3—lung cancer	0.000118	0.000577	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—MDM2—lung cancer	0.000118	0.000576	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.000118	0.000574	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—RAF1—lung cancer	0.000118	0.000574	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—MDM2—lung cancer	0.000116	0.000568	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.000116	0.000566	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—RAF1—lung cancer	0.000116	0.000566	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—AVP—lung cancer	0.000116	0.000563	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—BRAF—lung cancer	0.000115	0.000562	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—AVP—lung cancer	0.000114	0.000555	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000113	0.000552	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—BRAF—lung cancer	0.000113	0.000552	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—MAPK3—lung cancer	0.000113	0.000551	CbGpPWpGaD
Estazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000113	0.000549	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—APOA1—lung cancer	0.000112	0.000548	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—TF—lung cancer	0.000112	0.000547	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000112	0.000546	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—BRAF—lung cancer	0.000111	0.000543	CbGpPWpGaD
Estazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000111	0.000541	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—BRAF—lung cancer	0.000111	0.000539	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.00011	0.000538	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—ABCB1—lung cancer	0.00011	0.000537	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—JUN—lung cancer	0.00011	0.000537	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—BRAF—lung cancer	0.000109	0.000529	CbGpPWpGaD
Estazolam—GABRR1—Transmission across Chemical Synapses—HRAS—lung cancer	0.000108	0.000525	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—APOA1—lung cancer	0.000107	0.000523	CbGpPWpGaD
Estazolam—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	0.000104	0.000507	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—MDM2—lung cancer	0.000104	0.000506	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—RAF1—lung cancer	0.000103	0.000504	CbGpPWpGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—HRAS—lung cancer	0.000103	0.000501	CbGpPWpGaD
Estazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000102	0.000495	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—EP300—lung cancer	0.000101	0.000495	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—HPGDS—lung cancer	0.0001	0.000488	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—MDM2—lung cancer	9.94e-05	0.000485	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—RAF1—lung cancer	9.91e-05	0.000483	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—AVP—lung cancer	9.72e-05	0.000474	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTT1—lung cancer	9.71e-05	0.000474	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—MDM2—lung cancer	9.66e-05	0.000471	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—RAF1—lung cancer	9.63e-05	0.00047	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—lung cancer	9.61e-05	0.000469	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GCLC—lung cancer	9.6e-05	0.000468	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP2A6—lung cancer	9.6e-05	0.000468	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—CREBBP—lung cancer	9.52e-05	0.000464	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—BRAF—lung cancer	9.49e-05	0.000463	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—MDM2—lung cancer	9.48e-05	0.000463	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	9.47e-05	0.000462	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—RAF1—lung cancer	9.45e-05	0.000461	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—AVP—lung cancer	9.45e-05	0.000461	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—lung cancer	9.42e-05	0.000459	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—MDM2—lung cancer	9.32e-05	0.000455	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—RAF1—lung cancer	9.29e-05	0.000453	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—AVP—lung cancer	9.27e-05	0.000452	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—MDM2—lung cancer	9.26e-05	0.000452	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—RAF1—lung cancer	9.23e-05	0.00045	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	9.2e-05	0.000449	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—lung cancer	9.15e-05	0.000446	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—AVP—lung cancer	9.11e-05	0.000445	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—MDM2—lung cancer	9.09e-05	0.000444	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—CREBBP—lung cancer	9.08e-05	0.000443	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—RAF1—lung cancer	9.06e-05	0.000442	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—AVP—lung cancer	9.06e-05	0.000442	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	9.04e-05	0.000441	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—lung cancer	8.98e-05	0.000438	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—ALB—lung cancer	8.91e-05	0.000435	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—AVP—lung cancer	8.89e-05	0.000434	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	8.88e-05	0.000433	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—APOA1—lung cancer	8.83e-05	0.000431	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—lung cancer	8.83e-05	0.000431	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	8.82e-05	0.00043	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—lung cancer	8.77e-05	0.000428	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—APOA1—lung cancer	8.7e-05	0.000424	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	8.66e-05	0.000423	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—HRAS—lung cancer	8.63e-05	0.000421	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—lung cancer	8.61e-05	0.00042	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—ALB—lung cancer	8.5e-05	0.000415	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—HRAS—lung cancer	8.46e-05	0.000413	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—HRAS—lung cancer	8.33e-05	0.000406	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—HRAS—lung cancer	8.25e-05	0.000402	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	8.23e-05	0.000401	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP2E1—lung cancer	8.16e-05	0.000398	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—RAF1—lung cancer	8.06e-05	0.000393	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	8.05e-05	0.000393	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—MDM2—lung cancer	7.95e-05	0.000388	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—RAF1—lung cancer	7.92e-05	0.000386	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—HRAS—lung cancer	7.87e-05	0.000384	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—AVP—lung cancer	7.77e-05	0.000379	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—RAF1—lung cancer	7.69e-05	0.000375	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—AKT1—lung cancer	7.62e-05	0.000371	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	7.57e-05	0.000369	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—lung cancer	7.53e-05	0.000367	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—CREBBP—lung cancer	7.48e-05	0.000365	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—APOA1—lung cancer	7.43e-05	0.000363	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—CREBBP—lung cancer	7.36e-05	0.000359	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—APOA1—lung cancer	7.22e-05	0.000352	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—HRAS—lung cancer	7.12e-05	0.000347	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—APOA1—lung cancer	7.09e-05	0.000346	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—ALB—lung cancer	7e-05	0.000341	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—APOA1—lung cancer	6.97e-05	0.00034	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—APOA1—lung cancer	6.92e-05	0.000338	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—HRAS—lung cancer	6.92e-05	0.000337	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—ALB—lung cancer	6.89e-05	0.000336	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—APOA1—lung cancer	6.8e-05	0.000332	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—HRAS—lung cancer	6.79e-05	0.000331	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTP1—lung cancer	6.73e-05	0.000328	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—HRAS—lung cancer	6.68e-05	0.000326	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—IL6—lung cancer	6.65e-05	0.000324	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	6.64e-05	0.000324	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—HRAS—lung cancer	6.63e-05	0.000323	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—HRAS—lung cancer	6.51e-05	0.000318	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—HRAS—lung cancer	6.48e-05	0.000316	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—HRAS—lung cancer	6.38e-05	0.000311	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—RAF1—lung cancer	6.33e-05	0.000309	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—CREBBP—lung cancer	6.29e-05	0.000307	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—RAF1—lung cancer	6.23e-05	0.000304	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTM1—lung cancer	6.18e-05	0.000302	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—CREBBP—lung cancer	6.11e-05	0.000298	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	6.1e-05	0.000298	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—CREBBP—lung cancer	6e-05	0.000293	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—APOA1—lung cancer	5.94e-05	0.00029	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—CREBBP—lung cancer	5.9e-05	0.000288	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ALB—lung cancer	5.89e-05	0.000287	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP1A1—lung cancer	5.86e-05	0.000286	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—CREBBP—lung cancer	5.86e-05	0.000286	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	5.78e-05	0.000282	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—CREBBP—lung cancer	5.76e-05	0.000281	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ALB—lung cancer	5.72e-05	0.000279	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—HRAS—lung cancer	5.69e-05	0.000278	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ALB—lung cancer	5.62e-05	0.000274	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ALB—lung cancer	5.52e-05	0.000269	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ALB—lung cancer	5.49e-05	0.000268	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—HRAS—lung cancer	5.46e-05	0.000266	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ALB—lung cancer	5.39e-05	0.000263	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—RAF1—lung cancer	5.33e-05	0.00026	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—HRAS—lung cancer	5.3e-05	0.000259	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—HRAS—lung cancer	5.2e-05	0.000254	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—RAF1—lung cancer	5.18e-05	0.000252	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—COL4A3BP—lung cancer	5.16e-05	0.000252	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—AZIN2—lung cancer	5.16e-05	0.000252	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—HRAS—lung cancer	5.11e-05	0.000249	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—RAF1—lung cancer	5.08e-05	0.000248	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—HRAS—lung cancer	5.08e-05	0.000248	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—CREBBP—lung cancer	5.03e-05	0.000245	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—RAF1—lung cancer	4.99e-05	0.000244	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—HRAS—lung cancer	4.99e-05	0.000243	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—RAF1—lung cancer	4.96e-05	0.000242	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—RAF1—lung cancer	4.87e-05	0.000238	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ALB—lung cancer	4.71e-05	0.00023	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ATP5H—lung cancer	4.39e-05	0.000214	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—POMC—lung cancer	4.37e-05	0.000213	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—HRAS—lung cancer	4.36e-05	0.000213	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—RAF1—lung cancer	4.26e-05	0.000208	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PLBD1—lung cancer	3.91e-05	0.000191	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HSD17B10—lung cancer	3.57e-05	0.000174	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CKB—lung cancer	3.32e-05	0.000162	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTM2—lung cancer	3.12e-05	0.000152	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CNDP2—lung cancer	3.12e-05	0.000152	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—MTMR3—lung cancer	3.04e-05	0.000148	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PGAM1—lung cancer	2.96e-05	0.000144	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP2A7—lung cancer	2.83e-05	0.000138	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SDC4—lung cancer	2.77e-05	0.000135	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—RRM1—lung cancer	2.52e-05	0.000123	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA3—lung cancer	2.52e-05	0.000123	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—B4GALT5—lung cancer	2.37e-05	0.000116	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA4—lung cancer	2.3e-05	0.000112	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA2—lung cancer	2.24e-05	0.000109	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA1—lung cancer	2.17e-05	0.000106	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ABCC3—lung cancer	2.14e-05	0.000104	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—AKR1C1—lung cancer	2.07e-05	0.000101	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—UGT1A1—lung cancer	2.01e-05	9.82e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GNG11—lung cancer	1.94e-05	9.47e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ALDOA—lung cancer	1.85e-05	9.02e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NCOA3—lung cancer	1.79e-05	8.75e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ADCY1—lung cancer	1.75e-05	8.52e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ABCG2—lung cancer	1.75e-05	8.52e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HPGDS—lung cancer	1.71e-05	8.35e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ENO2—lung cancer	1.71e-05	8.35e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.7e-05	8.3e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTT1—lung cancer	1.66e-05	8.1e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP2A6—lung cancer	1.64e-05	8.01e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GCLC—lung cancer	1.64e-05	8.01e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ENO1—lung cancer	1.56e-05	7.59e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP2E1—lung cancer	1.4e-05	6.81e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NQO1—lung cancer	1.38e-05	6.73e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—STK11—lung cancer	1.24e-05	6.07e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTP1—lung cancer	1.15e-05	5.61e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CAT—lung cancer	1.12e-05	5.46e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ABCB1—lung cancer	1.09e-05	5.31e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—TYMS—lung cancer	1.07e-05	5.22e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTM1—lung cancer	1.06e-05	5.16e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP1A1—lung cancer	1e-05	4.89e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ERCC2—lung cancer	9.94e-06	4.85e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—APOA1—lung cancer	8.6e-06	4.2e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CG—lung cancer	7.85e-06	3.83e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—POMC—lung cancer	7.48e-06	3.65e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CREBBP—lung cancer	7.28e-06	3.55e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CD—lung cancer	6.9e-06	3.37e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ALB—lung cancer	6.82e-06	3.32e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CB—lung cancer	6.02e-06	2.94e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTGS2—lung cancer	5.96e-06	2.91e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTEN—lung cancer	5.2e-06	2.54e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—EP300—lung cancer	4.96e-06	2.42e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CA—lung cancer	3.67e-06	1.79e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—AKT1—lung cancer	3e-06	1.46e-05	CbGpPWpGaD
